Dr. Patrick Maguire
President and CEO
Dr. Patrick Maguire is a seasoned medical device and pharmaceutical company executive with over a decade of operational, strategic and managerial experience. He also is an experienced cardiovascular and thoracic surgeon. He joined CyberHeart as President, CEO, and Director in mid-2006, bringing a wide range of industry, medical and corporate experience, including the proven ability to develop and implement corporate strategies, execute clinical development plans and negotiate licensing.
Before joining CyberHeart, Dr. Maguire served as President, CEO and Director at Targent Inc., which he joined in 2002 and successfully negotiated the purchase of its oncology assets in 2006. Prior to Targent, Maguire joined VitaGen Inc. in 1999 as Vice President of Medical Affairs and Technology Development, where he oversaw the preparation of FDA submissions, international clinical trials for acute and chronic liver failure, and medical and industry collaborations.
Dr. Maguire is a Fellow of the American and Royal College of Surgeons and a member of more than 20 medical, academic and business societies. He studied under Dr. Norman Shumway at Stanford University Hospital. He then practiced as a cardiovascular and thoracic surgeon in La Jolla, Calif., and was a member of The Research Institute at Scripps Clinic from 1990 to 1997, where he acted as a principal investigator for medical devices and associated clinical trials.
Dr. Maguire received a Bachelor of Arts degree from Wesleyan University, Medical and Doctorate degrees in Physiology and Biophysics from Georgetown University, and a Master’s degree in Business Administration from Pepperdine University. He completed surgical and cardiovascular fellowships at The Peter Bent Brigham Hospital, Harvard University and Stanford University.
Executive Vice President
Alice Jack is a proven medical device industry executive with more than 20 years of management experience building emerging technology companies through strategic marketing, business development, clinical development strategy, training, clinical trial management, sales, and mergers and acquisitions. Ms. Jack, who serves as the company’s executive vice president, was hired by Thomas Fogarty and Rod Young in January 2006 as CyberHeart’s first employee. Her initial role was to determine the feasibility of CyberHeart’s non-invasive technology concept through researching data, developing and coordinating initial pre-clinical animal protocols and studies, and developing relationships with key opinion leaders within electrophysiology and radiosurgery. She authored the original business plan and was a member of the Series A fundraising team.
Ms. Jack is responsible for coordinating strategic planning to ensure that regulatory, clinical, technology development, reimbursement and marketing decisions support global market adoption and corporate value creation. She also is responsible for relationships with key opinion leaders, investors, media and other external stakeholders, in addition to clinical site selection, and identifying, evaluating and recommending additional business opportunities.
Prior to joining CyberHeart, Ms. Jack was vice president of Marketing and Sales for Vivant Medical Inc., a microwave ablation company that developed both capital equipment and disposable technology. Vivant Medical was acquired in 2005 by Tyco International Ltd. (now part of Covidien AG). Earlier in her career, Ms. Jack served as Vice President of Marketing and Business Development for Navius, a start-up cardiovascular stent, catheter and cardiac coronary brachytherapy company that was acquired by Endosonics Corp. (now owned by Volcano Therapeutics Inc.). In addition, she was Divisional Sales Director for the Western half of the U.S. for United States Surgical Corporation, after which she consulted for the company to direct their M&A activity within the cardiovascular market.
Ms. Jack also was the founder of Medical Interventions, a market development and sales distribution company that successfully pioneered new technologies to develop clinical programs at prominent medical centers, through the input and direction of advisory groups consisting of key opinion leaders and hospital management teams. She developed clinical training, market development, and sales management programs for surgical, interventional and minimally invasive cardiovascular companies as well as capital equipment companies, with a focus on cardiovascular and laser technology.
Ms. Jack received a Bachelor of Arts degree from the University of Illinois graduating Phi Beta Kappa and an Edmund J. James Scholar. In addition she earned a Master’s degree in Business Administration from Pepperdine University.